Ischemic preconditioning modulates the DNA methylation process of the rat heart to provide tolerance to withstand ischemia reperfusion injury and its associated mitochondrial dysfunction
3 Biotech · 2024-04 · 14 (4)
DOI: 10.1007/s13205-024-03965-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift 3 Biotech, online erschienen am 26.03.2024. Verfasst von Sri Rahavi Boovarahan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Lab, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamilnadu 613401 India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
DNA methylation plays a crucial role in the pathogenesis of myocardial ischemia reperfusion injury(I/R) and the I/R injury can be combated effectively by ischemia preconditioning (IPC), but the role is DNA methylation in this process is unknown. In this study, we uncovered the role of ischemic preconditioning (IPC)- mediated cardioprotection of rat myocardium by using a Langendorff rat heart model with 30 min of ischemia followed by 60 min of reperfusion. Heart conditioned with short cycles of ischemia and reperfusion (IPC procedure) prior to I/R protocol significantly reduced the I/R-induced global DNA hypermethylation level by 32% and the DNMT activity by 33% while rendering cardioprotection. Blocking the PI3K pathway via wortmannin not only negates the cardio-protection by IPC, but also increases the methylation of DNA by 75%. Besides, the correlation analysis showed a negative relationship between PI3K gene expression and the global DNA methylation level (r = - 0.8690, p = 0.0419) in IPC-treated rat hearts. Moreover, the global level DNA hypomethylation induced by IPC exhibited a regulatory effect on the genes involved in I/R pathology mediators like apoptosis (Caspase3), mitochondrial function (PGC 1α, TFAM, ND1) and oxidative stress (CuZnSOD, SOD2), and their corresponding function. The present study results provide novel evidence for the involvement of DNA methylation in the IPC procedure, and suggest DNA methylation as one of the potential therapeutic targets regulated by ischemic preconditioning in rat hearts subjected to ischemia reperfusion. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-03965-0.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular Biology Lab, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamilnadu 613401 India.
ORCID-Profile: Gino A Kurian
Zitieren
APA
Boovarahan, S. R., & Kurian, G. A. (2024). Ischemic preconditioning modulates the DNA methylation process of the rat heart to provide tolerance to withstand ischemia reperfusion injury and its associated mitochondrial dysfunction. 3 Biotech, 14(4). https://doi.org/10.1007/s13205-024-03965-0
Vancouver
Boovarahan SR, Kurian GA. Ischemic preconditioning modulates the DNA methylation process of the rat heart to provide tolerance to withstand ischemia reperfusion injury and its associated mitochondrial dysfunction. 3 Biotech. 2024;14(4). doi:10.1007/s13205-024-03965-0
BibTeX
@article{Boovarahan2024,
author = {Boovarahan, Sri Rahavi and Kurian, Gino A},
title = {Ischemic preconditioning modulates the DNA methylation process of the rat heart to provide tolerance to withstand ischemia reperfusion injury and its associated mitochondrial dysfunction},
journal = {3 Biotech},
year = {2024},
volume = {14},
number = {4},
doi = {10.1007/s13205-024-03965-0}
}
EUVIMED